Drug profile · INN
ondansetron hydrochloride
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride (ONDANSETRON HYDROCHLORIDE) is a serotonin 3a (5-ht3a) receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — ondansetron hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
ondansetron hydrochloride (ONDANSETRON HYDROCHLORIDE) is a serotonin 3a (5-ht3a) receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 3a (5-HT3a) receptor antagonist
Primary target: 5-hydroxytryptamine receptor 3A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ondansetron hydrochloride?
ondansetron hydrochloride (ONDANSETRON HYDROCHLORIDE) is a serotonin 3a (5-ht3a) receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ondansetron hydrochloride?
ONDANSETRON HYDROCHLORIDE is a marketed brand name for ondansetron hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ondansetron hydrochloride?
ondansetron hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.